Immunotherapy for Gallbladder Cancer
Immunotherapy is the use of medicines to help a person’s immune system better recognize and destroy cancer cells. Many of these drugs are being tested in clinical trials to see if they might help treat gallbladder cancer.
To learn more about how drugs that work on the immune system are used to treat cancer, see Cancer Immunotherapy.
- Written by
- References
The American Cancer Society medical and editorial content team
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as journalists, editors, and translators with extensive experience in medical writing.
Blair AB, Murphy A. Immunotherapy as a treatment for biliary tract cancers: A review of approaches with an eye to the future. Curr Probl Cancer. 2017 Oct [Epub ahead of print].
DeLeon TT, Ahn DH, Bogenberger JM, et al. Novel targeted therapy strategies for biliary tract cancers and hepatocellular carcinoma. Future Oncol. 2018;14(6):553-566.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Hepatobiliary Cancers. v.1.2018. Accessed at https://www.nccn.org/professionals/physician_gls/pdf/hepatobiliary.pdf on March 29, 2018.
Rojas-Sepúlveda , Tittarelli A, Gleisner MA, et al. Tumor lysate-based vaccines: on the road to immunotherapy for gallbladder cancer. Cancer Immunol Immunother. 2018 Mar 29. doi: 10.1007/s00262-018-2157-5. [Epub ahead of print]
Valle JW, Lamarca A, Goyal L, Barriuso J, Zhu AX. New Horizons for Precision Medicine in Biliary Tract Cancers. Cancer Discov. 2017;7(9):943-962.
Zaidi MY, Maithel SK. Updates on gallbladder cancer management. Current Oncology Reports. 2018; 20(21):1-7. [Epub ahead of print]
Last Revised: July 12, 2018
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.